JP MORGAN/CALL/ABBOTT LABORATORIES/100/0.1/21.06.24 Share Price

Warrant

DE000JS8FHV1

Real-time Bid/Ask 10:03:07 20/05/2024 pm IST
0.42 EUR / 0.43 EUR -19.81% Intraday chart for JP MORGAN/CALL/ABBOTT LABORATORIES/100/0.1/21.06.24
Current month-35.37%
1 month-52.68%
Date Price Change
20/24/20 0.49 -7.55%
17/24/17 0.53 +6.00%
16/24/16 0.5 0.00%
15/24/15 0.5 -13.79%
14/24/14 0.58 +3.57%

Delayed Quote Börse Stuttgart

Last update May 20, 2024 at 04:24 pm IST

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer J.P. Morgan
WKN JS8FHV
ISINDE000JS8FHV1
Date issued 28/02/2023
Strike 100 $
Maturity 21/06/2024 (32 Days)
Parity 10 : 1
Emission price 1.36
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.06
Lowest since issue 0.44
Spread 0.01
Spread %2.27%

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
104.1 USD
Average target price
126.1 USD
Spread / Average Target
+21.19%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW